Dobson JG Jr

Fredholm BB

Gazoni LM

Glover DK

Hale Sl

Jordan JE

Kilpatrick EL

Kloner RA

Lasley RD

Marala RB

Ramagopal MV

Rivo J

Robert A Kloner

Rohith Nayak

Sharon L Hale

Smits GJ

Sun WC

Thornton JD

Wangde Dai

Yang Z

Open Cardiovascular Medicine Journal

English

PubMed

Crossref

ATL 313, A Selective A2A Adenosine Receptor Agonist, Reduces Myocardial Infarct Size in a Rat Ischemia/Reperfusion Model

Additive protection against lung ischemia-reperfusion injury by adenosine A2A recep-172 The Open Cardiovascular Medicine Journal,

Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther

Adenosine A2 receptor function in rat ventricular myocytes. Cardiovasc Res

An adenosine A1 receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioningmimetic agent in rabbits. Cardiovasc Res

Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock

Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium.

Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization.

Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.

Evidence for an A2 adenosine receptor in human coronary arteries.

Immunological characterization of adenosine A2A receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther

Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J

Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation

International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev

Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation

Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophils.

Preconditioning stimuli and inadvertent preconditioning.

Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium. Am J Physiol Heart Circ Physiol

The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium. Am J Physiol Heart Circ Physiol

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2811859

ATL 313, A Selective A2A Adenosine Receptor Agonist, Reduces Myocardial Infarct Size in a Rat Ischemia/Reperfusion Model

Abstract

Similar works

Full text

Available Versions

Crossref